or
Remember me
Back
Everything relies on the results of the Field Tests. If they can replicate the data in a real world setting, then the FDA will fast track this submission and it will hit $100/share in no time. If not, this company drops to pennies!
Receive investor kits and email updates from Stockhouse and directly from these companies.